Sign in

CIK 0001771910 · Non-accelerated filer<br>Smaller reporting company

ADC Therapeutics SA

Sign in to watch
Ticker
ADCT
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
Phone
41 21 653 02 00
Business address
BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, Switzerland, 1066
  1. PRE 14A Proxy Proxy Statement (Preliminary)
  2. EFFECT Other Notice of Effectiveness
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Open-market buy 10% owner bought 800,000 shares at $2.81 ($2,248,000)
  9. 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
  10. 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
  11. 4 Open-market sale Director sold 1,193 shares at $2.89 ($3,448)
  12. 4 Open-market sale Director sold 1,437 shares at $2.89 ($4,153)
  13. 4 Open-market sale Director sold 1,437 shares at $2.89 ($4,153)
  14. 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
  15. 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 4 Grant or award Director acquired 40,000 shares (grant or award)

Page 8 of 23 · 441 filings